Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3C3 | Q8NEB9 | 12/20 | 0.41 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26812741 | 0.93 | PIK3C3 (0.39) | PIK3C3KCNH2NR1H2PIK3CAPIK3CB | |
| SCHEMBL26812747 | 0.86 | PIK3C3 (0.48) | PIK3C3PIK3CAPIK3CBPIK3CG | |
| SCHEMBL26812752 | 0.82 | PIK3C3 (0.45) | PIK3C3PIK3CAPIK3CBPIK3CG | |
| SCHEMBL21756936 | 0.73 | CYP2A13 (0.47) | CYP2A13KCNH2MAPT | |
| SCHEMBL26812028 | 0.71 | CYP2A13 (0.40) | CYP2A13KCNH2MAPT | |
| SCHEMBL26812754 | 0.70 | PIK3C3 (0.50) | PIK3C3 | |
| SCHEMBL27410325 | 0.70 | PIK3C3 (0.44) | PIK3C3PIK3CAPIK3CBPIK3CG | |
| SCHEMBL24721330 | 0.69 | PIK3C3 (0.44) | PIK3C3MAPTPIK3CAPIK3CBPIK3CG | |
| SCHEMBL21977884 | 0.69 | PIK3C3 (0.47) | PIK3C3PIK3CAPIK3CBPIK3CG | |
| SCHEMBL21955036 | 0.69 | PIK3C3 (0.47) | PIK3C3PIK3CAPIK3CBPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023220741-A1 | ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF | DICE MOLECULES SV, INC. (US) | 2023-11-16 | — | — | WO | disclosed |